Notably, the reduction in the rate of non-obesity-related cancers over time was of a similar magnitude, with surgery associated with a 32% lower hazard (HRadj = 0.68) in the highest insulin third. Here, INS is linked to obesity due to melanocortin 4 receptor deficiency.